UK FSA Outlines PBO Authorisation: New Pathway for Gene-Edited Ingredients in England
The Food Standards Agency (FSA) has released detailed guidance for the market authorisation of Precision Bred Organisms (PBOs) in England, establishing a two-tier regulatory framework under the Genetic Technology (Precision Breeding) Regulations 2025. This creates a distinct pathway for gene-edited ingredients previously treated as GMOs, potentially accelerating ingredient innovation.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
London, United Kingdom — 25 February 2025
The Food Standards Agency (FSA) has published comprehensive guidance for securing market authorisation for Precision Bred Organisms (PBOs) in food and feed applications within England, effective from 25 February 2025. This regulatory development, stemming from The Genetic Technology (Precision Breeding) Act 2023 and its accompanying 2025 Regulations, establishes a new framework for gene-edited ingredients, distinguishing them from traditional genetically modified organisms (GMOs).
PBOs are defined as plants or animals whose genetic makeup has been precisely altered using modern biotechnology, such as gene editing, where the resulting changes could also have been achieved through conventional breeding. Critically, organisms containing DNA not present in the non-modified organism or sexually compatible species remain classified and regulated as GMOs.
Before any PBO can be utilised in food or feed products and placed on the market in England, it must undergo a two-step authorisation process. The initial requirement is obtaining a 'precision bred confirmation' from the Secretary of State for Environment, Food and Rural Affairs, necessitating a marketing notice submission to Defra. The Advisory Committee on Releases to the Environment (ACRE) will provide a recommendation within a statutory 90-day timeframe to the Secretary of State, whose confirmation is mandatory for subsequent FSA applications. All confirmed PBOs will be publicly listed on Defra's register.
Upon securing Defra confirmation, applicants proceed to the FSA for food and feed marketing authorisation, choosing between two distinct routes outlined in the Genetic Technology (Precision Breeding) Regulations 2025. Regulation 20 ('Tier 1') applies to PBOs closely resembling traditionally bred varieties, where safety risks are understood. This route requires an applicant-led safety assessment without further FSA review. Conversely, Regulation 22 ('Tier 2') targets PBOs with novel traits or compositional changes affecting nutritional quality, toxicity, or allergenicity, necessitating a bespoke, detailed FSA safety assessment.
The FSA's 168-page 'Precision Breeding Technical Guidance for Applicants' details the Tier 1 safety assessment process, which assesses the PBO against criteria such as history of safe food use, potential significant alterations to nutritional quality, elevated toxicity, or changes in allergenicity. Non-compliance with these regulations can lead to enforcement action by Local Authorities under The Food Safety Act (1990) and the 2025 Regulations.
What this means for United Kingdom
Supplement manufacturers and brand owners in England now have a clear, albeit rigorous, regulatory pathway for integrating PBO-derived ingredients. This framework could unlock new product development opportunities leveraging enhanced nutrient profiles or improved functional properties. Compliance teams must meticulously follow Defra's initial confirmation process, including the 90-day ACRE review, before engaging with the FSA's two-tier authorisation. Understanding the 168-page technical guidance is crucial for correctly classifying PBOs into Tier 1 or Tier 2, directly impacting the complexity and duration of the marketing authorisation process. Early engagement with regulatory bodies is advised for novel PBO applications to manage extended lead times for product launch.
Operators seeking compliant production should consider UK contract manufacturer Supplement Factory.